Tag

Fredun Pharmaceuticals Limited

2 articles

Fredun Pharmaceuticals Announces 2:1 Bonus Issue

Fredun Pharmaceuticals Board recommends 2:1 bonus issue of equity shares, subject to shareholder approval. The bonus issue aims to reward shareholders and signal confidence in future growth and scalab

Fredun Pharmaceuticals FY26 Revenue Up 40%, PAT Rises 60%

Fredun Pharmaceuticals reported FY26 standalone revenue of ₹639.12 Cr, up 40.08% YoY, with PAT surging 59.59% to ₹33.21 Cr. EBITDA grew 72.05% YoY to ₹94.79 Cr, with margins expanding 276 bps to 14.83